Anlotinib - Globe Thesis

Keyword [Anlotinib] Result: 1 - 20 \| Page: 1 of 4
1.	Rab25 And TAM M2 Polarization Promote Erlotinib Resistance In NSCLC
2.	The Clinical Application Of CT Guided Percutaneous Lung Biopsy And The Effect Of Treatment Based On EGFR In Extensive Lung Squamous Cell Carcinoma
3.	The Efficacy Of Anlotinib As A Third-or Further-Line Treatment In Patients With Advanced NSCLC
4.	Clinical Effect And Safety Of Anlotinib In The Maintenance Treatment Of Extensive Small Cell Lung Cancer
5.	Short-term Clinical Efficacy And Analysis Of QOL Of Anlotinib In Treatment Of Third-line And Above Advanced Non-Small Cell Lung Cancer
6.	Treatment Of Lung Cancer With Small Antiangiogenic Drugs-Analysis Of The Real World
7.	Short-Term Efficacy Of Anlotinib Combined With S-1 Or RT In Patients With Locoregional Recurrence And Distant Metastases For Esophagus Carcinoma
8.	Analysis Of Efficacy And Prognostic Factors In Patients With Anlotinib At Advanced Non-small-cell Lung Cancer
9.	Effect Of Anlotinib On Lipid Metabolism And Its Underlying Mechanism
10.	The Retrospective Study Of Anlotinib In Second-line And Above Treatment For Advanced Lung Squamous Cell Carcinoma
11.	Clinical Study On The Treatment Of Advanced Non-small Cell Lung Cancer With Yifei Prescription Combined With Anlotinb
12.	The Effect And Mechanism Of Anlotinib Against Pancreatic Adenocarcinoma
13.	The Application Of Anlotinib In The Treatment Of Soft Tissue Sarcoma
14.	The Relationship Between Absolute Lymphocyte Count And Plasma D-dimer With The Short-term Efficacy And Prognosis Of The Anlotinib-administered Patients With Advanced Malignant Tumors
15.	Analysis Of Prognostic Factors In 111 Cases Of Cholangiocarcinoma And Preliminary Study On The Efficacy Of Arotinib In 10 Cases Of Biliary Tract Tumour
16.	Efficacy And Safety Of Anlotinib After Standard Treatment In Advanced Solid Tumors
17.	Efficacy And Safety Of Anlotinib Versus Docetaxel In Advanced Non-small Cell Lung Cancer After First-line Treatment Failure
18.	Experimental Study On EGFR-TKI Resistant Non-Small Cell Lung Cancer With Antiangiogenic Drugs
19.	Analysis Of Clinical Efficacy And Prognostic Factors Of Anlotinib Third-line And Above For Advanced Metastatic Colorectal Cancer
20.	The Clinical Efficacy Of Transarterial Chemoembolization Combined With Anlotinib In The Treatment Of Advanced Hepatocellular Carcinoma
<<First <Prev Next> Last>> Jump to